Made in DP success for dermatology research company Ziarco

Posted on 16/12/16

Discovery Park has long been a global centre for research with dermatology R&D experts Ziarco the latest to proudly wear the label #MadeinDP.

Earlier today the company announced its sale to Novartis, one of the world’s biggest pharmaceutical companies.

Ziarco’s key asset is lead investigational product, ZPL389, a potential first-in-class oral treatment for moderate-to-severe eczema.

The sale is a success story for Ziarco’s founders, four R&D leaders who spun out the company from Pfizer after the company scaled back its operations in 2011.

Read more on this story on the Ziarco website .

This is just one of many great stories from a site continuing to set the pace for #science + #enterprise in…
We'll be joining you @LocateInKent Pop over and see us at Stand 92!…
Pop along to @CanterburyCCUni for an informative #Kent Cancer Trust lecture on Tuesday, April 25. Doors @ 6pm Michael Berry Lecture Theatre